Literature DB >> 19066304

Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.

Antoine Lampron1, Isabelle Bourdeau, Sylvie Oble, Ariane Godbout, Walter Schürch, Philippe Arjane, Pavel Hamet, André Lacroix.   

Abstract

CONTEXT: Primary adrenal Cushing's syndrome can result from the aberrant adrenal expression of several hormone receptors; this mechanism has not been explored in detail in aldosterone-producing tumors.
OBJECTIVE: The objective of the study was to evaluate a 56-yr-old male patient with an aldosteronoma for the regulation of aldosterone secretion by aberrant hormone receptors.
RESULTS: Renin-independent stimulation of aldosterone secretion was observed in vivo after a mixed meal, oral glucose, or administration of glucose-dependent insulinotropic peptide (GIP), vasopressin, and tegaserod. The mixed meal-mediated stimulation of aldosterone was not present in five other cases of aldosteronoma. A smaller response of aldosterone after GIP infusion was observed in a normal subject. Aldosterone secretion was stimulated by GIP in primary cultures of this patient's aldosteronoma. Increased expression of GIP receptor was found in this aldosteronoma by real-time RT-PCR and immunohistochemistry. The GIP receptor protein was also found at lower levels in zona glomerulosa cells of the normal adjacent adrenal gland. Increased expression of serotonin 4 and ACTH receptors was also present in this aldosteronoma.
CONCLUSIONS: This case report provides new evidence of the implication of aberrant hormone receptors in the regulation of this aldosteronoma and suggests that further detailed studies of the role of aberrant hormone receptors in this frequent pathology should be undertaken.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066304     DOI: 10.1210/jc.2008-1340

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

2.  Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation.

Authors:  Matthew J Taylor; Matthew R Ullenbruch; Emily C Frucci; Juilee Rege; Mark S Ansorge; Celso E Gomez-Sanchez; Salma Begum; Edward Laufer; David T Breault; William E Rainey
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

3.  Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Authors:  Anne-Lise Lecoq; Constantine A Stratakis; Say Viengchareun; Ronan Chaligné; Lucie Tosca; Vianney Deméocq; Mirella Hage; Annabel Berthon; Fabio R Faucz; Patrick Hanna; Hadrien-Gaël Boyer; Nicolas Servant; Sylvie Salenave; Gérard Tachdjian; Clovis Adam; Vanessa Benhamo; Eric Clauser; Anne Guiochon-Mantel; Jacques Young; Marc Lombès; Isabelle Bourdeau; Dominique Maiter; Antoine Tabarin; Jérôme Bertherat; Hervé Lefebvre; Wouter de Herder; Estelle Louiset; André Lacroix; Philippe Chanson; Jérôme Bouligand; Peter Kamenický
Journal:  JCI Insight       Date:  2017-09-21

4.  A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.

Authors:  G A Kline; J L Pasieka; A Harvey; B So; V C Dias
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

5.  Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.

Authors:  C G Ziegler; J W Brown; A V Schally; A Erler; L Gebauer; A Treszl; L Young; L M Fishman; J B Engel; H S Willenberg; S Petersenn; G Eisenhofer; M Ehrhart-Bornstein; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

Review 6.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

Review 7.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 8.  Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.

Authors:  Hervé Lefebvre; Céline Duparc; Gaëtan Prévost; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-20       Impact factor: 5.555

Review 9.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

10.  Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.

Authors:  Matthieu St-Jean; Isabelle Bourdeau; Marc Martin; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.